ロード中...
Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects
Recent studies have highlighted the successes of chimeric antigen receptor-modified T- (CART-) cell-based therapy for B-cell malignancies, and early phase clinical trials have been launched in recent years. The few published clinical studies of CART cells in solid tumors have addressed safety and fe...
保存先:
| 出版年: | J Immunol Res |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Publishing Corporation
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4779545/ https://ncbi.nlm.nih.gov/pubmed/26998495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/3850839 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|